|
TRIM38 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.282600E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.284200E-02 |
| Normal-vs-Stage2 |
4.093800E-01 |
| Normal-vs-Stage3 |
9.353800E-01 |
| Normal-vs-Stage4 |
7.382200E-01 |
| Stage1-vs-Stage2 |
1.018210E-02 |
| Stage1-vs-Stage3 |
3.649600E-02 |
| Stage1-vs-Stage4 |
1.968610E-01 |
| Stage2-vs-Stage3 |
3.398000E-01 |
| Stage2-vs-Stage4 |
2.686600E-01 |
| Stage3-vs-Stage4 |
7.679400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.000180E-01 |
| Normal-vs-AfricanAmerican |
8.393700E-02 |
| Normal-vs-Asian |
1.473420E-01 |
| Caucasian-vs-AfricanAmerican |
5.109000E-01 |
| Caucasian-vs-Asian |
8.834600E-01 |
| AfricanAmerican-vs-Asian |
6.021600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.334400E-01 |
| Normal-vs-Female |
2.642800E-01 |
| Male-vs-Female |
3.861800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.097600E-02 |
| Normal-vs-Age(41-60Yrs) |
3.998000E-01 |
| Normal-vs-Age(61-80Yrs) |
6.028400E-01 |
| Normal-vs-Age(81-100Yrs) |
9.191200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.189560E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.217800E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.151000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.233800E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.330200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.706600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.790200E-02 |
| Classical-VS-Follicular |
9.70334923522387E-14 |
| Classical-VS-Other |
1.722200E-01 |
| Classical-VS-Normal |
7.203200E-03 |
| Tall-VS-Follicular |
7.676100E-03 |
| Tall-VS-Other |
7.492600E-01 |
| Tall-VS-Normal |
9.212000E-01 |
| Follicular-VS-Other |
2.632400E-01 |
| Follicular-VS-Normal |
3.522000E-03 |
| Other-VS-Normal |
8.087200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.947400E-01 |
| Normal-vs-N1 |
6.685000E-01 |
| N0-vs-N1 |
8.290200E-01 |
|
|
